CD19

Description- CD19 is in a panel of antibodies to aid in the characterization of B-cell malignancies. Its pattern or reactivity is membranous. In normal tissues, the CD19 detects protein expressed on the membrane of cells of B-cell lineage and staining is seen in the mantle zones and germinal centers of tonsil and tissue infiltrating B-lymphocytes. It is detected in hematological malignancies.

Methodology: Immunohistochemistry

TAT: 3-5 days

Specimen Preparation
Collect - tissue /or cell
Specimen Preparation- formal fix (10 % neutral buffered formalin) and paraffin enter specimen (FFPE specimens square measure needed). shield paraffin block or slides from uncontrolled heat. Transport tissue block or five unstained (3-micron thick sections), charged slides during a tissue transport kit. (Min: a pair of slides). If causing precut slides, don't over heat it.
Storage/Transport Temperature- At temperature or cold. Transport it in cooled instrumentation throughout weather.
Unacceptable conditions- i) Specimens submitted with non-marked/tagged tissue sort square measure rejected.
ii) Depleted specimens aren't tested.
Stability- i) Ambient: Indefinitely;
ii) Refrigerated: Indefinitely;
iii) Frozen: Unacceptable